Renerva, Inc., a Center for Life Science Ventures client developing medical devices for peripheral nerve repair, has received approval from the U.S. Food and Drug Administration to launch a first-in-human clinical study of its Renerva PNM-CAP™ nerve-cap device. The study will take place at The Ohio State University Wexner Medical Center and will be led by Principal Investigator Dr. Amy M....